Skip to main content

Advertisement

Log in

Development of the selective micropulse individual retinal therapy depends on age and type on the Fitzpatrick scale

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To develop a selective micropulse individual retinal therapy (SMIRT) based on the age and appearance type of the patient, to derive a formula for calculating power, and evaluate clinical efficacy for the treatment of central serous chorioretinopathy (CSCR).

Methods

73 patients (aged 30–65 years) with acute CSCR and types 1–4 on the Fitzpatrick scale were divided into 2 groups. In the first group (33 patients), the testing of the micropulse mode (50 µs, 2.4%, 10 ms, 100 µm, 0.4–1.9 W) on the Navilas 577 s laser system defined as selective by computer modeling was performed. A logistic regression function based on probability damage detection (PDD) of the 1584 laser spots from power, age, and type on the Fitzpatrick scale was constructed. PDD is the probability of detecting the laser spots using the autofluorescence method. The second group was divided into 4 subgroups of 10 eyes each. Groups 2.1, 2.2, and 2.3 were treated without preliminary testing. The power for Groups 2.1, 2.2, and 2.3 was obtained with the inverse PDD function, so that PDD was 50%, 70%, and 90%, respectively. Control group 2.4 went without treatment.

Results

The transmission and absorption coefficients of laser radiation of the eye depend on the age and the Fitzpatrick scale type. In Groups 2.1–2.3, complete resorption of subretinal fluid was observed 3 months after CSCR treatment in 5 (P < 0.35), 8 (P < 0.023), and 10 eyes (P < 0.0008) out of 10, respectively.

Conclusion

The developed SMIRT is effective for CSCR treatment with PDD 90%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Schuele G, Rumohr M, Huettmann G, Brinkmann R (2005) RPE damage thresholds and mechanisms for laser exposure in the microsecond-to-millisecond time regimen. Invest Ophthalmol Vis Sci 46:714–719. https://doi.org/10.1167/iovs.04-0136

    Article  Google Scholar 

  2. Roider J, Michaud NA, Flotte TJ, Birngruber R (1992) Response of the retinal pigment epithelium to selective photocoagulation. Arch Ophthalmol 110:1786–1792. https://doi.org/10.1001/archopht.1992.01080240126045

    Article  CAS  Google Scholar 

  3. Roider J, Hillenkamp F, Flotte T, Birngruber R (1993) Microphotocoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci USA 90:8643–8647. https://doi.org/10.1073/pnas.90.18.8643

    Article  CAS  Google Scholar 

  4. Ivanova EV, Volodin PL, Guskov AV (2022) Determination of micropulse modes with targeted damage to the retinal pigment epithelium using computer modeling for the development of selective individual micropulse retinal therapy. Curr Eye Res 47:107–114. https://doi.org/10.1080/02713683.2021.1962360

    Article  CAS  Google Scholar 

  5. Wang J, Quan Y, Dalal R, Palanker D (2017) Comparison of continuous-wave and micropulse modulation in retinal laser therapy. Invest Ophthalmol Vis Sci 58:4722–4732. https://doi.org/10.1167/iovs.17-21610

    Article  CAS  Google Scholar 

  6. Lavinsky D, Wang J, Huie P et al (2016) Nondamaging retinal laser therapy: rationale and applications to the macula. Investigative Opthalmol Vis Sci 57:2488. https://doi.org/10.1167/iovs.15-18981

    Article  CAS  Google Scholar 

  7. Volodin PL, Ivanova EV, Solomin V (2018) The possibilities of modern diagnostic methods and computer data processing using the FemtoScan program to identify weak thermal damage of retinal pigment epithelium cells. Laser Med 1:52–57

    Google Scholar 

  8. Volodin PL, Ivanova EV (2020) Clinical evaluation of individualized and navigated microsecond pulsing laser for acute central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina 51:512–520. https://doi.org/10.3928/23258160-20200831-06

    Article  Google Scholar 

  9. Volodin PL, Doga AV, Ivanova EV et al (2019) The personalized approach to the chronic central serous chorioretinopathy treatment based on the navigated micropulse laser technology. Ophthalmol Russia 15:394–404. https://doi.org/10.18008/1816-5095-2018-4-394-404

    Article  Google Scholar 

  10. Hammer M, Schweitzer D (2002) Quantitative reflection spectroscopy at the human ocular fundus. Phys Med Biol 47:179–191. https://doi.org/10.1088/0031-9155/47/2/301

    Article  Google Scholar 

  11. Shu X, Liu W, Zhang HF (2015) Monte Carlo investigation on quantifying the retinal pigment epithelium melanin concentration by photoacoustic ophthalmoscopy. J Biomed Opt 20:106005. https://doi.org/10.1117/1.jbo.20.10.106005

    Article  Google Scholar 

  12. Geeraets W, Williams R, Chan G et al (1962) The relative absorption of thermal energy in retina and choroid. Invest Ophthalmol Vis Sci 1:340–347

    CAS  Google Scholar 

  13. Fitzpatrick TB (1988) The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124:869–871. https://doi.org/10.1001/archderm.124.6.869

    Article  CAS  Google Scholar 

  14. He SY, McCulloch CE, Boscardin WJ et al (2014) Self-reported pigmentary phenotypes and race are significant but incomplete predictors of Fitzpatrick skin phototype in an ethnically diverse population. J Am Acad Dermatol 71:731–737. https://doi.org/10.1016/j.jaad.2014.05.023

    Article  Google Scholar 

  15. Sarna T, Burke JM, Korytowski W et al (2003) Loss of melanin from human RPE with aging: possible role of melanin photooxidation. Exp Eye Res 76:89–98. https://doi.org/10.1016/S0014-4835(02)00247-6

    Article  CAS  Google Scholar 

  16. Weale RA (1988) Age and the transmittance of the human crystalline lens. J Physiol 395:577–587. https://doi.org/10.1113/jphysiol.1988.sp016935

    Article  CAS  Google Scholar 

  17. Gawęcki M (2015) Increase in central retinal edema after subthreshold diode micropulse laser treatment of chronic central serous chorioretinopathy. Case Rep Ophthalmol Med 2015:1–4. https://doi.org/10.1155/2015/813414

    Article  Google Scholar 

  18. Scholz P, Altay L, Fauser S (2017) A review of subthreshold micropulse laser for treatment of macular disorders. Adv Ther 34:1528–1555. https://doi.org/10.1007/s12325-017-0559-y

    Article  Google Scholar 

  19. Gawęcki M (2019) Micropulse laser treatment of retinal diseases. J Clin Med 8:242. https://doi.org/10.3390/jcm8020242

    Article  CAS  Google Scholar 

  20. Ohkoshi K, Tsuiki E, Kitaoka T, Yamaguchi T (2010) Visualization of subthreshold micropulse diode laser photocoagulation by scanning laser ophthalmoscopy in the retro mode. Amer J Ophthalmol 150. https://doi.org/10.1016/j.ajo.2010.06.022

  21. Luttrull JK, Sramek C, Palanker D et al (2012) Long-term safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema. Retina 32:375–386. https://doi.org/10.1097/IAE.0b013e3182206f6c

    Article  Google Scholar 

  22. Zhou L, Lai K, Jin L, et al (2021) Subthreshold micropulse laser vs. conventional laser for central serous chorioretinopathy: a randomized controlled clinical trial. Front Med 8. https://doi.org/10.3389/fmed.2021.682264

  23. Maltsev DS, Kulikov AN, Chhablani J (2019) Clinical application of fluorescein angiography-free navigated focal laser photocoagulation in central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina 50:E118–E124. https://doi.org/10.3928/23258160-20190401-16

    Article  Google Scholar 

  24. Maruko I, Koizumi H, Hasegawa T, et al (2017) Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy. PLoS One 12. https://doi.org/10.1371/journal.pone.0184112

  25. Ambiya V, Goud A, Mathai A et al (2016) Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy. Clin Ophthalmol 10:1513–1519. https://doi.org/10.2147/OPTH.S112431

    Article  Google Scholar 

  26. Lanzetta P, Furlan F, Morgante L et al (2008) Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol 18:934–940. https://doi.org/10.1177/112067210801800613

    Article  CAS  Google Scholar 

  27. Luttrull JK (2016) Low-intensity/high-density subthreshold diode micropulse laser for central serous chorioretinopathy. Retina 36:1658–1663. https://doi.org/10.1097/IAE.0000000000001005

    Article  Google Scholar 

  28. Kim YJ, Lee YG, Lee DW, Kim JH (2018) Selective retina therapy with real-time feedback-controlled dosimetry for treating acute idiopathic central serous chorioretinopathy in Korean patients. J Ophthalmol 2018. https://doi.org/10.1155/2018/6027871

  29. Elsner H, Pörksen E, Klatt C et al (2006) Selective retina therapy in patients with central serous chorioretinopathy. Graefe’s Arch Clin Exp Ophthalmol 244:1638–1645. https://doi.org/10.1007/s00417-006-0368-5

    Article  CAS  Google Scholar 

  30. Kim YJ, Kim SY, Ha S, Moon D, Seong S, Kwon OW, Park HS (2019) Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years. Eye (Lond). 33(5):819-825. https://doi.org/10.1038/s41433-018-0309-7.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elena V. Ivanova.

Ethics declarations

Ethical approval

All procedures performed in this study were in accordance with the tenets of the Declaration of Helsinki 1964 and its amendments. This study was approved by the Institutional Review Board: Interuniversity Ethics Committee (Protocol 11).

Informed consent

All patients provided written consent and were informed of the surgical procedures beforehand, including the testing phase that was performed to determine the personalized parameters for the treatment.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Presented virtually at the Association for Research in Vision and Ophthalmology (ARVO) May 2-6, 2021, San Francisco, CA, USA .

This article received support from the mentorship team. Further information can be found in the editorial https://link.springer.com/article/10.1007/s00417-019-04518-5.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ivanova, E.V., Volodin, P.L. Development of the selective micropulse individual retinal therapy depends on age and type on the Fitzpatrick scale. Graefes Arch Clin Exp Ophthalmol 261, 381–390 (2023). https://doi.org/10.1007/s00417-022-05800-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-022-05800-9

Keywords

Navigation